As on January 04, 2021, Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD) started slowly as it slid -1.84% to $11.18. During the day, the stock rose to $11.44 and sunk to $11.08 before settling in for the price of $11.39 at the close. Taking a more long-term approach, IRWD posted a 52-week range of $7.99-$14.06.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 41.20%. Meanwhile, its Annual Earning per share during the time was 17.80%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 129.70%. This publicly-traded company’s shares outstanding now amounts to $159.85 million, simultaneously with a float of $155.36 million. The organization now has a market capitalization sitting at $1.81 billion. At the time of writing, stock’s 50-day Moving Average stood at $11.28, while the 200-day Moving Average is $10.36.
It is imperative to bring your focus towards the efficiency factor of the conglomerate that has a total of 317 employees. It has generated 1,351,461 per worker during the last fiscal year. Meanwhile, its income per employee was 185,940. The stock had 4.32 Receivables turnover and 1.17 Total Asset turnover. For the Profitability, stocks gross margin was +93.12, operating margin was +27.32 and Pretax Margin of +13.76.
Ironwood Pharmaceuticals Inc. (IRWD) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Drug Manufacturers – Specialty & Generic industry. According to the most recent insider trade that took place on Dec 04, this organization’s Chief Accounting Officer sold 5,639 shares at the rate of 12.50, making the entire transaction reach 70,488 in total value, affecting insider ownership by 93,041. Preceding that transaction, on Nov 11, Company’s Chief Accounting Officer sold 3,561 for 11.75, making the whole transaction’s value amount to 41,842. This particular insider is now the holder of 93,041 in total.
Ironwood Pharmaceuticals Inc. (IRWD) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 9/29/2020, the company posted $0.23 earnings per share (EPS) for the quarter, besting the agreed prediction (set at $0.15) by $0.08. This company achieved a net margin of +13.76. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.19 per share during the current fiscal year.
Ironwood Pharmaceuticals Inc.’s EPS increase for this current 12-month fiscal period is 129.70% and is forecasted to reach 1.19 in the upcoming year.
Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD) Trading Performance Indicators
Let’s observe the current performance indicators for Ironwood Pharmaceuticals Inc. (IRWD). The Stock has managed to achieve an average true range (ATR) of 0.35. Alongside those numbers, its PE Ratio stands at $16.02, and its Beta score is 1.46. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.53. Similarly, its price to free cash flow for trailing twelve months is now 12.88.
In the same vein, IRWD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.70, a figure that is expected to reach 0.28 in the next quarter, and analysts are predicting that it will be 1.19 at the market close of one year from today.
Technical Analysis of Ironwood Pharmaceuticals Inc. (IRWD)
During the previous 9 days, stock’s Stochastic %D was recorded 9.65% While, its Average True Range was 0.34.
Raw Stochastic average of Ironwood Pharmaceuticals Inc. (IRWD) in the period of the previous 100 days is set at 65.05%, which indicates a major rise in contrast to 8.20% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 23.00% that was lower than 38.04% volatility it exhibited in the past 100-days period.